Abstract
Photodynamic therapy is a therapeutic option to treat cancer and other diseases. PDT is used every day in dermatology, and recent developments in the treatment of glioblastoma, mesothelioma or prostate have demonstrated the efficacy of this modality. In order to improve the efficacy of PDT, different strategies are under development, such as the use of targeted PS or nanoparticles to improve selectivity and the design of light devices to better monitor the light dose. Due to the low penetration of light into tissue, another way to improve the efficacy of PDT to treat deep tumors is the use of upconversion NPs or bi-photon absorption compounds. These compounds can be excited in the red part of the spectrum. A relatively new approach, which we will call PDTX, is the use of X-rays instead of UV-visible light for deeper penetration into tissue. The principle of this technique will be described, and the state-of-art literature concerning this modality will be discussed. First, we will focus on various photosensitizers that have been used in combination with X-ray irradiation. To improve the efficacy of this modality, nanoparticles have been designed that allow the conversion of high-energy ionizing radiation into UV-visible light; these are potential candidates for the PDTX approach. They will be discussed at the end of this review.
Similar content being viewed by others
References
X. Wen, Y. Li and M. R. Hamblin, Photodynamic therapy in dermatology beyond non-melanoma cancer: An update, Photodiagn. Photodyn. Ther., 2017, 19, 140–152.
J. Akimoto, Photodynamic Therapy for Malignant Brain Tumors, Neurol. Med. Chir., 2016, 56, 151–157.
J. S. Friedberg, Photodynamic therapy for malignant pleural mesothelioma, J. Natl. Compr. Cancer Network, 2012, 10, S75–S79.
S. S. Taneja, Re: padeliporfin vascular-targeted photo-dynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): An open-label, phase 3, randomised controlled trial editorial comment, J. Urol., 2017, 198, 255–256.
H. Azaïs, C. Frochot, A. Grabarz, S. K. Bach, L. Colombeau, N. Delhem, S. Mordon and P. Collinet, Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epi-thelial ovarian cancer, Gynecol. Obstet. Fertil. Senol., 2017, 45, 190–196.
E. E. Kamarulzaman, R. Vanderesse, A. M. Gazzali, M. Barberi-Heyob, C. Boura, C. Frochot, O. Shawkataly, A. Aubry and H. A. Wahab, Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anti-cancer application, J. Biomol. Struct. Dyn., 2017, 35, 26–45.
E. Thomas, L. Colombeau, M. Gries, T. Peterlini, C. Mathieu, N. Thomas, C. Boura, C. Frochot, R. Vanderesse, F. Lux, M. Barberi-Heyob and O. Tillement, Ultrasmall AGulX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblas-toma, Int. J. Nanomed., 2017, 12, 7075–7088.
S. Mordon, C. Cochrane, J. B. Tylcz, N. Betrouni, L. Mortier and V. Koncar, Light emitting fabric techno-logies for photodynamic therapy, Photodiagn. Photodyn. Ther., 2015, 12, 1–8.
L. Colombeau, S. Acherar, F. Baros, P. Arnoux, A. M. Gazzali, K. Zaghdoudi, M. Toussaint, R. Vanderesse and C. Frochot, in Light-Responsive Nanostructured Systems for Applications in Nanomedicine, ed. S. Sortino, 2016, vol. 370, pp. 113–134.
W. Fan, P. Huang and X. Chen, Overcoming the Achilles' heel of photodynamic therapy, Chem. Soc. Rev., 2016, 45, 6488–6519.
D. K. Chatterjee, L. S. Fong and Y. Zhang, Nanoparticles in photodynamic therapy: An emerging paradigm, Adv. Drug Delivery Rev., 2008, 60, 1627–1637.
W. Chen, Nanoparticle fluorescence based technology for biological applications, J. Nanosci. Nanotechnol., 2008, 8, 1019–1051.
J. A. Coulter, W. B. Hyland, J. Nicol and F. J. Currell, Radiosensitising nanoparticles as novel cancer thera-peutics-pipe dream or realistic prospect?, Clin. Oncol., 2013, 25, 593–603.
J. Hu, Y. Tang, A. H. Elmenoufy, H. Xu, Z. Cheng and X. Yang, Nanocomposite-based photodynamic therapy strategies for deep tumor treatment, Small, 2015, 11, 5860–5887.
A. Kamkaew, F. Chen, Y. Zhan, R. L. Majewski and W. Cai, Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy, ACS Nano, 2016, 10, 3918–3935.
P. Retif, S. Pinel, M. Toussaint, C. Frochot, R. Chouikrat, T. Bastogne and M. Barberi-Heyob, Nanoparticles for radi-ation therapy enhancement: the key parameters, Theranostics, 2015, 5, 1030–1044.
D. R. Cooper, D. Bekah and J. L. Nadeau, Gold nano-particles and their alternatives for radiation therapy enhancement, Front. Chem., 2014, 2, 86.
W. Ngwa, R. Kumar, S. Sridhar, H. Korideck, P. Zygmanski, R. A. Cormack, R. Berbeco and G. M. Makrigiorgos, Targeted radiotherapy with gold nanoparticles: current status and future perspectives, Nanomedicine, 2014, 9, 1063–1082.
P. Juzenas, W. Chen, Y. P. Sun, M. A. Coelho, R. Generalov, N. Generalova and I. L. Christensen, Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer, Adv. Drug Delivery Rev., 2008, 60, 1600–1614.
K. Benstead and J. V. Moore, The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin, Br.J. Cancer, 1990, 62, 48–53.
A. Colasanti, A. Kisslinger, M. Quarto and P. Riccio, Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model, Acta Biochim. Pol., 2004, 51, 1039–1046.
J. Liu, Y. Yang, W. Zhu, X. Yi, Z. Dong, X. Xu, M. Chen, K. Yang, G. Lu, L. Jiang and Z. Liu, Nanoscale metal-organic frameworks for combined photodynamic & radi-ation therapy in cancer treatment, Biomaterials, 2016, 97, 1–9.
A. R. Montazerabadi, A. Sazgarnia, M. H. Bahreyni-Toosi, A. Ahmadi and A. Aledavood, The effects of combined treatment with ionizing radiation and indo-cyanine green-mediated photodynamic therapy on breast cancer cells, J. Photochem. Photobiol., B, 2012, 109, 42–49.
B. W. Pogue, J. A. O'Hara, E. Demidenko, C. M. Wilmot, I. A. Goodwin, B. Chen, H. M. Swartz and T. Hasan, Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity, Cancer Res., 2003, 63, 1025–1033.
J. G. Post, J. A. te Poele, Y. Oussoren and F. A. Stewart, The influence of intravesical photodynamic therapy on sub-sequent bladder irradiation tolerance, Radiother. Oncol., 1995, 37, 124–130.
C. Prinsze, L. C. Penning, T. M. Dubbelman and J. VanSteveninck, Interaction of photodynamic treatment and either hyperthermia or ionizing radiation and of ionizing radiation and hyperthermia with respect to cell killing of L929 fibroblasts, Chinese hamster ovary cells, and T24 human bladder carcinoma cells, Cancer Res., 1992, 52, 117–120.
J. Qiu, Q. Xiao, X. Zheng, L. Zhang, H. Xing, D. Ni, Y. Liu, S. Zhang, Q. Ren, Y. Hua, K. Zhao and W. Bu, Single W18O49 nanowires: A multifunctional nanoplatform for computed tomography imaging and photothermal/photo-dynamic/radiation synergistic cancer therapy, Nano Res., 2015, 8, 3580–3590.
A. Sazgarnia, A. R. Montazerabadi, M. H. Bahreyni-Toosi and A. Ahmadi, Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells, Lasers Med. Sci., 2013, 28, 1533–1539.
J. Shi, Z. Chen, L. Wang, B. Wang, L. Xu, L. Hou and Z. Zhang, A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging, Acta Biomater., 2016, 29, 282–297.
J. Winther, J. Overgaard and N. Ehlers, The effect of photodynamic therapy alone and in combination with misonidazole or X-rays for management of a retinoblas-toma-like tumour, Photochem. Photobiol., 1988, 47, 419–423.
J. Xu, J. Gao and Q. Wei, Combination of photodynamic therapy with radiotherapy for cancer treatment, J. Nanomater., 2016, 2016, 7.
X. Yu, X. Tang, J. He, X. Yi, G. Xu, L. Tian, R. Zhou, C. Zhang and K. Yang, Polydopamine nanoparticle as a multifunctional nanocarrier for combined radiophotody-namic therapy of cancer, Part. Part. Syst. Charact., 2017, 34, 1600296.
P. Hambsch, Y. P. Istomin, D. A. Tzerkovsky, I. Patties, J. Neuhaus, R. D. Kortmann, S. Schastak and A. Glasow, Efficient cell death induction in human glioblastoma cells by photodynamic treatment with Tetrahydroporphyrin-Tetratosylat (THPTS) and ionizing irradiation, Oncotarget., 2017, 8, 72411–72423.
M. Zhang, Z. Cui, R. Song, B. Lv, Z. Tang, X. Meng, X. Chen, X. Zheng, J. Zhang, Z. Yao and W. Bu, SnWO4- based nanohybrids with full energy transfer for largely enhanced photodynamic therapy and radiotherapy, Biomaterials, 2017, 155, 135–144.
W. Fan, B. Shen, W. Bu, F. Chen, Q. He, K. Zhao, S. Zhang, L. Zhou, W. Peng, Q. Xiao, D. Ni, J. Liu and J. Shi, A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/ photodynamic therapy and simultaneous MR/UCL imaging, Biomaterials, 2014, 35, 8992–9002.
D. Balland, R. Guillard and J. C. Andre, Industrial photo-chemistry.6. Light-distribution in photopolymerizable composite-materials and heterogeneities observed in light-source used for the photoreaction, Polym. Photochem., 1984, 4, 111–133.
C. Braun and J. C. Andre, Industrial photochemistry.7. Light-distribution in a diffusing medium of titanium-dioxide in water, J. Photochem., 1985, 28, 13–29.
P. Boissard, French thesis, Université de Toulouse III Paul Sabatier, 2012.
C. M. Yang, French thesis, Paris XI, 2014.
N. Y. Morgan, G. Kramer-Marek, P. D. Smith, K. Camphausen and J. Capala, Nanoscintillator conju-gates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters, Radiat. Res., 2009, 171, 236–244.
A. L. Bulin, A. Vasil'ev, A. Belsky, D. Amans, G. Ledoux and C. Dujardin, Modelling energy deposition in nanos-cintillators to predict the efficiency of the X-ray-induced photodynamic effect, Nanoscale, 2015, 7, 5744–5751.
J. C. Finlay, PDT driven by energy-converting materials: a theoretical analysis, in SPIE BiOS, 2009, vol. 7164, p. 7.
W. Hausmann, Die sensibilisierende wirkung des hemato-porphyrin, Biochem. Z., 1910, 30, 276–316.
M. R. Hamblin and P. Mróz, in Engineering in Medicine & Biology series, Artech House series, 2008.
R. Bonnet, in Advanced chemistry texts, Gordon and Breach Science Publishers, 2000, pp. 1029–3654.
R. L. Lipson and E. J. Baldes, The photodynamic pro-perties of a particular hematoporphyrin derivative, Arch. Dermatol., 1960, 82, 508–516.
M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, A. Hofstetter, E. Duhmke and G. Jori, Porphyrins as radio-sensitizing agents for solid neoplasms, Curr. Pharm. Des., 2003, 9, 2024–2035.
S. Schwartz, K. Absolon and H. Vermund, Some relation-ships of porphyrins, X-ray, and tumors, Univ. Minn. Med. Bull., 1955, 27, 1–37.
L. Cohen and S. Schwartz, Modification of radiosensitivity by porphyrins. II. Transplanted rhabdomyosarcoma in mice, Cancer Res., 1966, 26, 1769–1773.
J. Moan and E. O. Pettersen, X-irradiation of human cells in culture in the presence of hematoporphyrin, Int. J. Radiat. Biol., 1981, 40, 107–109.
G. Kavarnos, R. Nath and P. Bongiorni, Visible-light and X irradiations of chinese hamster lung cells treated with hematoporphyrin derivative, Radiat. Res., 1994, 137, 196–201.
F. Bistolfi, Red radioluminescence and radiochemilumi-nescence: premises for a photodynamic tumour therapy with X-rays and haematoporphyrin derivatives. A working hypothesis, Panminerva Med., 2000, 42, 69–75.
C. Austerlitz, V. L. Bormann de Souza, D. M. T. Campos, C. Kurachi, V. Bagnato and C. Sibata, Enhanced response of the Fricke solution doped with hematoporphyrin under X-rays irradiation, Braz. Arch. Biol. Technol., 2008, 51, 271–279.
C. J. Byrne, L. V. Marshallsay and A. D. Ward, The compo-sition of Photofrin II, J. Photochem. Photobiol., B, 1990, 6, 13–27.
T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 1998, 90, 889–905.
L. W. Ma, V. Iani and J. Moan, Combination therapy: photochemotherapy; electric current; and ionizing radi-ation. Different combinations studied in a WiDr human colon adenocarcinoma cell line, J. Photochem. Photobiol., B, 1993, 21, 149–154.
M. Schaffer, P. M. Schaffer, L. Corti, G. Sotti, A. Hofstetter, G. Jori and E. Duhmke, Photofrin II as an efficient radio-sensitizing agent in an experimental tumor, Onkologie, 2001, 24, 482–485.
M. Schaffer, P. M. Schaffer, M. Vogesser, B. Ertl-Wagner, J. Rauch, R. Oberneder, G. Jori, A. Hofstetter and E. Duhmke, Application of Photofrin II as a specific radio-sensitising agent in patients with bladder cancer-a report of two cases, Photochem. Photobiol. Sci., 2002, 1, 686–689.
M. Schaffer, P. M. Schaffer, L. Corti, M. Gardiman, G. Sotti, A. Hofstetter, G. Jori and E. Duhmke, Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model, J. Photochem. Photobiol., B, 2002, 66, 157–164.
U. Kulka, M. Schaffer, A. Siefert, P. M. Schaffer, A. Olsner, K. Kasseb, A. Hofstetter, E. Duhmke and G. Jori, Photofrin as a radiosensitizer in an in vitro cell survival assay, Biochem. Biophys. Res. Commun., 2003, 311, 98–103.
M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, G. Jori, E. Duhmke and A. Hofstetter, The Application of Photofrin II as a sensitizing agent for ionizing radiation: A new approach in tumor therapy?, Curr. Med. Chem., 2005, 12, 1209–1215.
M. Schaffer, P. M. Schaffer, A. Hofstetter, E. Duhmke and G. Jori, On the double role of Photofrin as a photo-and a radio-sensitising agent: A possible new combination therapy for tumours, Photochem. Photobiol. Sci., 2002, 1, 438–439.
A. B. Ormond and H. S. Freeman, Dye Sensitizers for Photodynamic Therapy, Materials, 2013, 6, 817–840.
K. Berg, Z. Luksiene, J. H. Moan and L. W. Ma, Combined treatment of ionizing-radiation and photosensitization by 5-aminolevulinic acid-indiced protoporphyrin-IX, Radiat. Res., 1995, 142, 340–346.
J. Takahashi and M. Misawa, Characterization of reactive oxygen species generated by protoporphyrin IX under X-ray irradiation, Radiat. Phys. Chem., 2009, 78, 889–898.
J. Yamamoto, S. I. Ogura, T. Tanaka, T. Kitagawa, Y. Nakano, T. Saito, M. Takahashi, D. Akiba and S. Nishizawa, Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro, Oncol. Rep., 2012, 27, 1748–1752.
J. Takahashi, M. Misawa, M. Murakami, T. Mori, K. Nomura and H. Iwahashi, 5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor model, SpringerPlus, 2013, 2, 602.
J. Takahashi, M. Misawa and H. Iwahashi, Gene expression profiling can predict the fate of HeLa cells exposed to X-ray irradiation with or without protopor-phyrin accumulation, Genomics Data, 2015, 5, 192–194.
J. Takahashi, M. Misawa and H. Iwahashi, Transcriptome analysis of porphyrin-accumulated and X-ray-irradiated cell cultures under limited proliferation and non-lethal conditions, Microarrays, 2015, 4, 25–40.
J. Takahashi, M. Misawa and H. Iwahashi, Combined treatment with X-ray irradiation and 5-aminolevulinic acid elicits better transcriptomic response of cell cycle-related factors than X-ray irradiation alone, Int. J. Radiat. Biol., 2016, 92, 774–789.
R. M. Acheson, Acridines, John Wiley & Sons, Inc., New York, 1956.
K. Kusuzaki, H. Murata, T. Matsubara, H. Satonaka, T. Wakabayashi, A. Matsumine and A. Uchida, Acridine orange could be an innovative anticancer agent under photon energy, In Vivo, 2007, 21, 205–214.
S. Hashiguchi, K. Kusuzaki, H. Murata, H. Takeshita, M. Hashiba, T. Nishimura, T. Ashihara and Y. Hirasawa, Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma, Oncology, 2002, 62, 85–93.
K. Kusuzaki, S. Hosogi, E. Ashihara, T. Matsubara, H. Satonaka, T. Nakamura, A. Matsumine, A. Sudo, A. Uchida, H. Murata, N. Baldini, S. Fais and Y. Marunaka, Translational research of photodynamic therapy with acridine orange which targets cancer acidity, Curr. Pharm. Des., 2012, 18, 1414–1420.
K. Kusuzaki, H. Murata, T. Matsubara, S. Miyazaki, K. Shintani, M. Seto, A. Matsumine, H. Hosoi, T. Sugimoto and A. Uchida, Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas, Photochem. Photobiol., 2005, 81, 705–709.
T. Matsubara, K. Kusuzaki, A. Matsumine, H. Murata, Y. Marunaka, S. Hosogi, A. Uchida and A. Sudo, Photodynamic therapy with acridine orange in musculos-keletal sarcomas, J. Bone Jt. Surg., Br. Vol., 2010, 92, 760–762.
K. Kusuzaki, H. Murata, T. Matsubara, S. Miyazaki, A. Okamura, M. Seto, A. Matsumine, H. Hosoi, T. Sugimoto and A. Uchida, Clinical trial of photodynamic therapy using acridine orange with/without low dose radi-ation as new limb salvage modality in musculoskeletal sarcomas, Anticancer Res., 2005, 25, 1225–1235.
T. Nakamura, K. Kusuzaki, T. Matsubara, A. Matsumine, H. Murata and A. Uchida, A new limb salvage surgery in cases of high-grade soft tissue sarcoma using photo-dynamic surgery, followed by photo-and radiodynamic therapy with acridine orange, J. Surg. Oncol., 2008, 97, 523–528.
T. Matsubara, K. Kusuzaki, A. Matsumine, H. Murata, H. Satonaka, K. Shintani, T. Nakamura, H. Hosoi, T. Iehara, T. Sugimoto and A. Uchida, A new therapeutic modality involving acridine orange excitation by photon energy used during reduction surgery for rhabdomyosar-comas, Oncol. Rep., 2009, 21, 89–94.
T. Matsubara, K. Kusuzaki, A. Matsumine, H. Murata, T. Nakamura, A. Uchida and A. Sudo, Clinical outcomes of minimally invasive surgery using acridine orange for musculoskeletal sarcomas around the forearm, compared with conventional limb salvage surgery after wide resec-tion, J. Surg. Oncol., 2010, 102, 271–275.
K. Kusuzaki, T. Takai, H. Yoshimura, K. Inoue, S. Takai and N. Baldini, Clinical trial of radiotherapy after intrave-nous injection of acridine orange for patients with cancer, Anticancer Res., 2018, 38, 481–489.
J. A. O'Hara, E. B. Douple, M. J. Abrams, D. J. Picker, C. M. Giandomenico and J. F. Vollano, Potentiation of radiation-induced cell kill by synthetic matalllo-porphyrins, Int. J. Radiat. Oncol., Biol., Phys., 1989, 16, 1049–1052.
M. A. Capella and S. Menezes, Synergism between electro-lysis and methylene blue photodynamic action in Escherichia coli, Int. J. Radiat. Biol., 1992, 62, 321–326.
T. Matsubara, K. Kusuzaki, A. Matsumine, H. Satonaka, K. Shintani, T. Nakamura and A. Uchida, Methylene blue in place of acridine orange as a photosensitizer in photo-dynamic therapy of osteosarcoma, In Vivo, 2008, 22, 297–303.
S. Douillard, D. Olivier and T. Patrice, In vitro and in vivo evaluation of Radachlorin (R) sensitizer for photodynamic therapy, Photochem. Photobiol. Sci., 2009, 8, 405–413.
R. Ghoodarzi, V. Changizi, A. R. Montazerabadi and N. Eyvazzadaeh, Assessing of integration of ionizing radi-ation with Radachlorin-PDT on MCF-7 breast cancer cell treatment, Lasers Med. Sci., 2016, 31, 213–219.
A. Kumar and A. Dhawan, Genotoxic and carcinogenic potential of engineered nanoparticles: an update, Arch. Toxicol., 2013, 87, 1883–1900.
P. Boffetta, A. Soutar, J. W. Cherrie, F. Granath, A. Andersen, A. Anttila, M. Blettner, V. Gaborieau, S. J. Klug, S. Langard, D. Luce, F. Merletti, B. Miller, D. Mirabelli, E. Pukkala, H. O. Adami and E. Weiderpass, Mortality among workers employed in the titanium dioxide production industry in Europe, Cancer Causes Control, 2004, 15, 697–706.
T. A. Kuhlbusch, C. Asbach, H. Fissan, D. Göhler and M. Stintz, Nanoparticle exposure at nanotechnology work-places: A review, Part. Fibre Toxicol., 2011, 8, 22.
G. Oberdörster, A. Maynard, K. Donaldson, V. Castranova, J. Fitzpatrick, K. Ausman, J. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. Monteiro-Riviere, D. Warheit and H. Yang, Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy, Part. Fibre Toxicol., 2005, 2, 8.
E. Gaffet, Nanomaterials: A review of the definitions, applications, health effects. How to implement secure development, C. R. Phys., 2011, 12, 648–658.
M. E. Samberg, S. J. Oldenburg and N. A. Monteiro-Riviere, Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro, Environ. Health Perspect., 2010, 118, 407–413.
Y. Wang, Z. Chen, T. Ba, J. Pu, T. Chen, Y. Song, Y. Gu, Q. Qian, Y. Xu, K. Xiang, H. Wang and G. Jia, Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles, Small, 2013, 9, 1742–1752.
M. Hofmann-Amtenbrink, D. W. Grainger and H. Hofmann, Nanoparticles in medicine: Current chal-lenges facing inorganic nanoparticle toxicity assessments and standardizations, Nanomed. Nanotechnol. Biol. Med., 2015, 11, 1689–1694.
S. K. Murthy, Nanoparticles in modern medicine: State of the art and future challenges, Int. J. Nanomed., 2007, 2, 129–141.
K. Shubhika, Nanotechnology and medicine-The upside and the downside, Int. J. Drug Dev. Res., 2012, 5, 1–10.
E. Vlachou, E. Chipp, E. Shale, Y. T. Wilson, R. Papini and N. S. Moiemen, The safety of nanocrystalline silver dres-sings on burns: a study of systemic silver absorption, Burns, 2007, 33, 979–985.
C. W. Lam, J. T. James, R. McCluskey, S. Arepalli and R. L. Hunter, A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks, Crit. Rev. Toxicol., 2006, 36, 189–217.
R. A. Baan, Carcinogenic hazards from inhaled carbon black, titanium dioxide, and talc not containing asbestos or asbestiform fibers: recent evaluations by an IARC Monographs Working Group, Inhalation Toxicol., 2007, 19 (Suppl 1), 213–228.
D. H. M. Dam, K. S. B. Culver, I. Kandela, R. C. Lee, K. Chandra, H. Lee, C. Mantis, A. Ugolkov, A. P. Mazar and T. W. Odom, Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars, Nanomed. Nanotechnol. Biol. Med., 2015, 11, 671–679.
J. Zhao, P. Lee, M. J. Wallace and M. P. Melancon, Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity, Curr. Pharm. Des., 2015, 21, 4240–4251.
E. Boisselier and D. Astruc, Gold nanoparticles in nano-medicine: preparations, imaging, diagnostics, therapies and toxicity, Chem. Soc. Rev., 2009, 38, 1759–1782.
W. H. De Jong and P. J. A. Borm, Drug delivery and nano-particles: Applications and hazards, Int. J. Nanomed., 2008, 3, 133–149.
M. R. Gwinn and V. Vallyathan, Nanoparticles: Health effects-Pros and cons, Environ. Health Perspect., 2006, 114, 1818–1825.
M. A. Maurer-Jones, K. C. Bantz, S. A. Love, B. J. Marquis and C. L. Haynes, Toxicity of therapeutic nanoparticles, Nanomedicine, 2009, 4, 219–241.
L. Zhang, F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer and O. C. Farokhzad, Nanoparticles in medicine: thera-peutic applications and developments, Clin. Pharmacol. Ther., 2008, 83, 761–769.
S. Nazir, T. Hussain, A. Ayub, U. Rashid and A. J. MacRobert, Nanomaterials in combating cancer: Therapeutic applications and developments, Nanomed. Nanotechnol. Biol. Med., 2014, 10, 19–34.
P. Zhao, S. Y. Dong, J. Bhattacharyya and M. N. Chen, iTEP Nanoparticle-Delivered Salinomycin Displays an Enhanced Toxicity to Cancer Stem Cells in Orthotopic Breast Tumors, Mol. Pharm., 2014, 11, 2703–2712.
Y. F. Wang, P. F. Liu, L. H. Qiu, Y. Sun, M. J. Zhu, L. Y. Gu, W. Di and Y. R. Duan, Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice, Biomaterials, 2013, 34, 4068–4077.
A. Shafei, W. El-Bakly, A. Sobhy, O. Wagdy, A. Reda, O. Aboelenin, A. Marzouk, K. Habak, R. Mostafa, M. A. Ali and M. Ellithy, A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer, Biomed. Pharmacother., 2017, 95, 1209–1218.
Y. S. R. Elnaggar, S. M. Etman, D. A. Abdelmonsif and O. Y. Abdallah, Intranasal piperine-loaded chitosan nano-particles as brain-targeted therapy in Alzheimer’s disease: Optimization, biological efficacy, and potential toxicity, J. Pharm. Sci., 2015, 104, 3544–3556.
H. L. Chen, W. B. Nan, X. J. Wei, Y. Wang, F. Lv, H. B. Tang, Y. H. Li, C. Y. Zhou, J. T. Lin, W. L. Zhu and Q. Q. Zhang, Toxicity, pharmaco-kinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy, Artif. Cells, Nanomed., Biotechnol., 2017, 45, 1115–1122.
L. Chen, L. Wu, F. Liu, X. Y. Qi, Y. R. Ge and S. Shen, Azo-functionalized Fe3O4 nanoparticles: a near-infrared light triggered drug delivery system for combined therapy of cancer with low toxicity, J. Mater. Chem. B, 2016, 4, 3660–3669.
H. I. Hung, O. J. Klein, S. W. Peterson, S. R. Rokosh, S. Osseiran, N. H. Nowell and C. L. Evans, PLGA nano-particle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro, Sci. Rep., 2016, 6, 33234.
H. X. Wang, J. P. Wu, L. Xu, K. Xie, C. Chen and Y. H. Dong, Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity, Chem. Commun., 2017, 53, 2618–2621.
A. W. Dunn, S. M. Ehsan, D. Mast, G. M. Pauletti, H. Xu, J. M. Zhang, R. C. Ewing and D. L. Shi, Photothermal effects and toxicity of Fe3O4 nanoparticles via near infra-red laser irradiation for cancer therapy, Mater. Sci. Eng., C, 2015, 46, 97–102.
B. Samanta, H. Yan, N. O. Fischer, J. Shi, D. J. Jerry and V. M. Rotello, Protein-passivated Fe3O4 nanoparticles: low toxicity and rapid heating for thermal therapy, J. Mater. Chem., 2008, 18, 1204–1208.
D. Q. Wang, L. J. Meng, Z. F. Fei, C. Hou, J. G. Long, L. Zeng, P. J. Dyson and P. Huang, Multi-layered tumor-targeting photothermal-doxorubicin releasing nanotubes eradicate tumors in vivo with negligible systemic toxicity, Nanoscale, 2018, 10, 8536–8546.
H. Y. Jiang, D. Chen, D. B. Guo, N. Wang, Y. Su, X. Jin, G. S. Tong and X. Y. Zhu, Zwitterionic gold nanorods: low toxicity and high photothermal efficacy for cancer therapy, Biomater. Sci., 2017, 5, 686–697.
Y. Luo, H. Wu, C. Feng, K. Xiao, X. Yang, Q. Liu, T. Lin, H. Zhang, J. H. Walton, Y. Ajena, Y. Hu, K. S. Lam and Y. Li, “One-Pot” Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics, Theranostics, 2017, 7, 3901–3914.
A. Uppal, B. Jain, P. K. Gupta and K. Das, Photodynamic action of Rose Bengal silica nanoparticle complex on breast and oral cancer cell lines, Photochem. Photobiol., 2011, 87, 1146–1151.
Y. Zhang, N. Li, H. Suh and D. J. Irvine, Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity, Nat. Commun., 2018, 9, 6.
A. Jafarizad, A. Aghanejad, M. Sevim, O. Metin, J. Barar, Y. Omidi and D. Ekinci, Gold nanoparticles and reduced graphene oxide-gold nanoparticle composite materials as covalent drug delivery systems for breast cancer treatment, ChemistrySelect, 2017, 2, 6663–6672.
S. S. Lee, P. J. R. Roche, P. N. Giannopoulos, E. J. Mitmaker, M. Tamilia, M. Paliouras and M. A. Trifiro, Prostate-specific membrane antigen-directed nanoparticle targeting for extreme nearfield ablation of prostate cancer cells, Tumor Biol., 2017, 39, 1–12.
L. Tao, K. Zhang, Y. J. Sun, B. Q. Jin, Z. J. Zhang and K. Yang, Anti-epithelial cell adhesion molecule mono-clonal antibody conjugated fluorescent nanoparticle bio-sensor for sensitive detection of colon cancer cells, Biosens. Bioelectron., 2012, 35, 186–192.
Y. Cheng, A. C. Samia, J. Li, M. E. Kenney, A. Resnick and C. Burda, Delivery and Efficacy of a Cancer Drug as a Function of the Bond to the Gold Nanoparticle Surface, Langmuir, 2010, 26, 2248–2255.
W. Chen and J. Zhang, Using nanoparticles to enable sim-ultaneous radiation and photodynamic therapies for cancer treatment, J. Nanosci. Nanotechnol., 2006, 6, 1159–1166.
V. V. Bakhmetyev, T. S. Minakova, S. V. Mjakin, L. A. Lebedev, A. B. Vlasenko, A. A. Nikandrova, I. A. Ekimova, N. S. Eremina, M. M. Sychov and A. Ringuede, Synthesis and surface characterization of nanosized Y2O3:Eu and YAG:Eu luminescent phosphors which are useful in photodynamic therapy of cancer, Eur. J. Nanomed., 2016, 8, 173–184.
W. Chen and J. Zhang, Nanoparticles based photo-dynamic therapy and methods of making and using some, US 20070218049, 2007.
W. Chen, Nanoparticle self-lighting photodynamic therapy for cancer teatment, J. Biomed. Nanotechnol., 2008, 4, 369–376.
S. Kascakova, M. Refregiers and A. Guiliani, Radioluminescent compound for radiotherapy and deep photodynamic therapy and device for deep photodynamic therapy, France Pat., WO2015/059379, 2016.
W. Lin, C. He and K. Lu, Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radio-therapy, chemotherapy, immunotherapy, and any combination thereof, USA Pat., WO2016061256A1, 2016.
J. Takahashi and M. Misawa, Analysis of potential radio-sensitizing materials for X-ray-induced photodynamic therapy, NanoBiotechnology, 2007, 3, 116–126.
Z. Liu, L. Xiong, G. Ouyang, L. Ma, S. Sahi, K. Wang, L. Lin, H. Huang, X. Miao, W. Chen and Y. Wen, Investigation of copper cysteamine nanoparticles as a new type of radiosensitiers for colorectal carcinoma treatment, Sci. Rep., 2017, 7, 9290.
L. Ma, X. Zou and W. Chen, A new X-ray activated nano-particle photosensitizer for cancer treatment, J. Biomed. Nanotechnol., 2014, 10, 1501–1508.
C. C. Yang, Y. J. Sun, P. H. Chung, W. Y. Chen, W. Swieszkowski, W. M. Tian and F. H. Lin, Development of Ce-doped TiO2 activated by X-ray irradiation for alterna-tive cancer treatment, Ceram. Int., 2017, 43, 12675–12683.
J. P. Scaffidi, M. K. Gregas, B. Lauly, Y. Zhang and T. Vo-Dinh, Activity of psoralen-functionalized nanoscintillators against cancer cells upon X-ray excitation, ACS Nano, 2011, 5, 4679–4687.
L. Ma, X. Zou, B. Bui, W. Chen, K. H. Song and T. Solberg, X-ray excited ZnS:Cu,Co afterglow nanoparticles for photodynamic activation, Appl. Phys. Lett., 2014, 105, 013702.
L. Ma, X. Zou, M. Hossu and W. Chen, Synthesis of ZnS: Ag,Co water-soluble blue afterglow nanoparticles and application in photodynamic activation, Nanotechnology, 2016, 27, 315602.
S. Sadjadpour, S. Safarian, S. J. Zargar and N. Sheibani, Antiproliferative effects of ZnO, ZnO-MTCP, and ZnO-CuMTCP nanoparticles with safe intensity UV and X-ray irradiation, Biotechnol. Appl. Biochem., 2016, 63, 113–124.
W.-J. Kuo, Y.-C. Wang, M.-H. Chen, F.-I. Tung and T.-Y. Liu, Study of a novel vehicle developed for enhancing the efficacy of radiation therapy, Ceram. Int., 2017, 43, S789–S796.
Z. Mohammadi, A. Sazgarnia, O. Rajabi and M. Seilanian Toosi, Comparative study of X-ray treatment and photo-dynamic therapy by using 5-aminolevulinic acid conju-gated gold nanoparticles in a melanoma cell line, Artif. Cells, Nanomed., Biotechnol., 2017, 45, 467–473.
H. Chen, X. Sun, G. D. Wang, K. Nagata, Z. Hao, A. Wang, Z. Li, J. Xie and B. Shen, LiGa5O8:Cr-based theranostic nanoparticles for imaging-guided X-ray induced photo-dynamic therapy of deep-seated tumors, Mater. Horiz., 2017, 4, 1092–1101.
K. Popovich, L. Prochazkova, I. T. Pelikanova, M. Vlk, M. Palkovsky, V. Jary, M. Nikl, V. Mucka, E. Mihokova and V. Cuba, Preliminary study on singlet oxygen production using CeF3:Tb3+@SiO2-PpIX, Radiat. Meas., 2016, 90, 325–328.
S. L. Yefimova, T. N. Tkacheva, P. O. Maksimchuk, I. I. Bespalova, K. O. Hubenko, V. K. Klochkov, A. V. Sorokin and Y. V. Malyukin, GdVO4:Eu3+ nano-particles-Methylene Blue complexes for PDT: Electronic excitation energy transfer study, J. Lumin., 2017, 192, 975–981.
E. Abliz, J. E. Collins, H. Bell and D. B. Tata, Novel appli-cations of diagnostic X-rays in activating a clinical photo-dynamic drug: Photofrin II through X-ray induced visible luminescence from “rare-earth” formulated particles, J. X-Ray Sci. Technol., 2011, 19, 521–530.
S. Clement, W. Deng, E. Camilleri, B. C. Wilson and E. M. Goldys, X-ray induced singlet oxygen generation by nanoparticle-photosensitizer conjugates for photo-dynamic therapy: determination of singlet oxygen quantum yield, Sci. Rep., 2016, 6, 19954.
Y. Tang, J. Hu, A. H. Elmenoufy and X. Yang, Highly efficient FRET system capable of deep photodynamic therapy established on X-ray excited mesoporous LaF3:Tb scintillating nanoparticles, ACS Appl. Mater. Interfaces, 2015, 7, 12261–12269.
H. Chen, G. D. Wang, Y. J. Chuang, Z. Zhen, X. Chen, P. Biddinger, Z. Hao, F. Liu, B. Shen, Z. Pan and J. Xie, Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment, Nano Lett., 2015, 15, 2249–2256.
G. D. Wang, H. T. Nguyen, H. Chen, P. B. Cox, L. Wang, K. Nagata, Z. Hao, A. Wang, Z. Li and J. Xie, X-ray induced photodynamic therapy: A combination of radiotherapy and photodynamic therapy, Theranostics, 2016, 6, 2295–2305.
M. H. Chen, Y. J. Jenh, S. K. Wu, Y. S. Chen, N. Hanagata and F. H. Lin, Non-invasive Photodynamic Therapy in Brain Cancer by Use of Tb3+-Doped LaF3 Nanoparticles in Combination with Photosensitizer Through X-ray Irradiation: A Proof-of-Concept Study, Nanoscale Res. Lett., 2017, 12, 62.
Y. Liu, W. Chen, S. Wang and A. G. Joly, Investigation of water-soluble X-ray luminescence nanoparticles for photo-dynamic activation, Appl. Phys. Lett., 2008, 92, 043901.
F. Rossi, E. Bedogni, F. Bigi, T. Rimoldi, L. Cristofolini, S. Pinelli, R. Alinovi, M. Negri, S. C. Dhanabalan, G. Attolini, F. Fabbri, M. Goldoni, A. Mutti, G. Benecchi, C. Ghetti, S. Lannotta and G. Salviati, Porphyrin conju-gated SiC/SiOx nanowires for X-ray-excited photodynamic therapy, Sci. Rep., 2015, 5, 7606.
R. Tatti, M. Timpel, M. V. Nardi, F. Fabbri, R. Rossi, L. Pasquardini, A. Chiasera, L. Aversa, K. Koshmak, A. Giglia, L. Pasquali, T. Rimoldi, L. Cristofolini, G. Attolini, S. Varas, S. Iannotta, R. Verucchi and G. Salviati, Functionalization of SiC/SiOx nanowires with a porphyrin derivative: a hybrid nanosystem for X-ray induced singlet oxygen generation, Mol. Syst. Des. Eng., 2017, 2, 165–172.
C. L. Pan, M. H. Chen, F. I. Tung and T. Y. Liu, A nanove-hicle developed for treating deep-seated bacteria using low-dose X-ray, Acta Biomater., 2017, 47, 159–169.
H. T. Kim, K. H. Kim, G. H. Choi, S. Jheon, S. H. Park, B. I. Kim, K. Hyodo, M. Ando and J. K. Kim, in 12th World Congress of the International Photodynamic Association: Photodynamic Therapy: Back to the Future, ed. D. H. Kessel, 2009, vol. 7380.
S. A. Osseni, S. Lechevallier, M. Verelst, C. Dujardin, J. Dexpert-Ghys, D. Neumeyer, M. Leclercq, H. Baaziz, D. Cussac, V. Santran and R. Mauricot, New nanoplatform based on Gd2O2S:Eu3+ core: synthesis, characterization and use for in vitro bio-labelling, J. Mater. Chem., 2011, 21, 18365–18372.
A. Kleinauskas, S. Rocha, S. Sahu, Y. P. Sun and P. Juzenas, Carbon-core silver-shell nanodots as sensi-tizers for phototherapy and radiotherapy, Nanotechnology, 2013, 24, 325103.
C. Zhang, K. Zhao, W. Bu, D. Ni, Y. Liu, J. Feng and J. Shi, Marriage of scintillator and semiconductor for synchro-nous radiotherapy and deep photodynamic therapy with diminished oxygen dependence, Angew. Chem., Int. Ed., 2015, 54, 1770–1774.
K. Kirakci, P. Kubat, K. Fejfarova, J. Martincik, M. Nikl and K. Lang, X-ray inducible luminescence ands inglet oxygen sensitization by an octahedral molybdenum cluster compound: A new class of nanoscintillators, Inorg. Chem., 2016, 55, 803–809.
Z. Guo, S. Zhu, Y. Yong, X. Zhang, X. Dong, J. Du, J. Xie, Q. Wang, Z. Gu and Y. Zhao, Synthesis of BSA-coated BiOI@Bi2S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photother-mal synergistic therapy of tumor, Adv. Mater., 2017, 29, 1704136.
A. L. Bulin, C. Truillett, R. Chouikrat, F. Lux, C. Frochot, D. Amans, G. Ledoux, O. Tillement, P. Perriat, M. Barberi-Heyob and C. Dujardin, X-ray-induced singlet oxygen acti-vation with nanoscintillator-coupled porphyrins, J. Phys. Chem. C, 2013, 117, 21583–21589.
X. Zou, M. Yao, L. Ma, M. Hossu, X. Han, P. Juzenas and W. Chen, X-ray-induced nanoparticle-based photodynamic therapy of cancer, Nanomedicine, 2014, 9, 2339–2351.
S. Kascáková, A. Giuliani, S. Lacerda, A. Pallier, P. Mercere, É. Tóth and M. Réfrégiers, X-ray-induced radiophotodynamic therapy (RPDT) using lanthanide micelles: Beyond depth limitations, Nano Res., 2015, 8, 2373–2379.
W. Fan, B. Shen, W. Bu, X. Zheng, Q. He, Z. Cui, D. Ni, K. Zhao, S. Zhang and J. Shi, Intranuclear biophotonics by smart design of nuclear-targeting photo-/radio-sensitizers co-loaded upconversion nanoparticles, Biomaterials, 2015, 69, 89–98.
H.-P. Chen, F.-I. Tung, M.-H. Chen and T.-Y. Liu, A mag-netic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation, J. Controlled Release, 2016, 226, 182–192.
K. Kudinov, D. Bekah, D. Cooper, S. Shastry, C. Hill, S. Bradforth and J. Nadeau, Presented in part at the SPIE BiOS, 2016.
M. Zahedifar, E. Sadeghi, M. M. Shanei, A. Sazgarnia and M. Mehrabi, Afterglow properties of CaF2:Tm nano-particles and its potential application in photodynamic therapy, J. Lumin., 2016, 171, 254–258.
H. Homayoni, L. Ma, J. Zhang, S. K. Sahi, L. H. Rashidi, B. Bui and W. Chen, Synthesis and conjugation of Sr2MgSi2O7:Eu2+, Dy3+ water soluble afterglow nano-particles for photodynamic activation, Photodiagn. Photodyn. Ther., 2016, 16, 90–99.
R. Chouikrat, F. Baros, J. C. Andre, R. Vanderesse, B. Viana, A. L. Bulin, C. Dujardin, P. Arnoux, M. Verelst and C. Frochot, A photosensitizer lanthanide nanoparticle formulation that induces singlet oxygen with direct light excitation, but not by photon or X-ray energy transfer, Photochem. Photobiol., 2017, 93, 1439–1448.
S. Clement, W. Chen, A. G. Anwer and E. M. Goldys, Verteprofin conjugated to gold nanoparticles for fluo-rescent cellular bioimaging and X-ray mediated photo-dynamic therapy, Microchim. Acta, 2017, 184, 1765–1771.
S. Kokotov, A. Lewis, R. Neumann and S. Amrusi, X-ray induced visible luminescence of porphyrins, Photochem. Photobiol., 1994, 59, 385–387.
G. Lan, K. Ni, R. Xu, K. Lu, Z. Lin, C. Chan and W. Lin, Nanoscale metal-organic layers for deeply penetrating X-ray-induced photodynamic therapy, Angew. Chem., Int. Ed., 2017, 56, 12102–12106.
J. Douglas, ICRU Report 50—Prescribing, recording and reporting photon beam therapy, Med. Phys., 1994, 21, 833–834.
K. C. Wei, K. C. Yang, L. W. Chen, W. C. Liu, W. C. Chen, W. Y. Chiou and P. C. Lai, Management of fluoroscopy-induced radiation ulcer: One-stage radical excision and immediate reconstruction, Sci. Rep., 2016, 6, 35875.
R. Waksman, P. E. McEwan, T. I. Moore, R. Pakala, F. D. Kolodgie, D. G. Hellinga, R. C. Seabron, S. J. Rychnovsky, J. Vasek, R. W. Scott and R. Virmani, PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque pro-gression, J. Am. Coll. Cardiol., 2008, 52, 1024–1032.
S. Michels and U. Schmidt-Erfurth, Photodynamic therapy with verteporfin: a new treatment in ophthalmology, Semin. Ophthalmol., 2001, 16, 201–206.
J. N. Silva, P. Filipe, P. Morliere, J. C. Maziere, J. P. Freitas, M. M. Gomes and R. Santus, Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic, Biomed. Mater. Eng., 2008, 18, 319–327.
Y. Lee and E. D. Baron, Photodynamic therapy: current evidence and applications in dermatology, Semin. Cutaneous Med. Surg., 2011, 30, 199–209.
R. M. Szeimies, S. Lischner, W. Philipp-Dormston, T. Walker, D. Hiepe-Wegener, K. Feise, M. Podda, W. Prager, E. Kohl and S. Karrer, Photodynamic therapy for skin rejuvenation: treatment options-results of a con-sensus conference of an expert group for aesthetic photo-dynamic therapy, J. Dtsch. Dermatol. Ges., 2013, 11, 632–636.
P. Babilas, S. Schreml, M. Landthaler and R. M. Szeimies, Photodynamic therapy in dermatology: state-of-the-art, Photodermatol., Photoimmunol. Photomed., 2010, 26, 118–132.
P. Meisel and T. Kocher, Photodynamic therapy for peri-odontal diseases: state of the art, J. Photochem. Photobiol., B, 2005, 79, 159–170.
K. Konopka and T. Goslinski, Photodynamic therapy in dentistry, J. Dent. Res., 2007, 86, 694–707.
T. G. Cotter, Apoptosis and cancer: the genesis of a research field, Nat. Rev. Cancer, 2009, 9, 501–507.
G. Bozzini, P. Colin, N. Betrouni, P. Nevoux, A. Ouzzane, P. Puech, A. Villers and S. Mordon, Photodynamic therapy in urology: what can we do now and where are we heading?, Photodiagn. Photodyn. Ther., 2012, 9, 261–273.
L. Costa, M. A. Faustino, M. G. Neves, A. Cunha and A. Almeida, Photodynamic inactivation of mammalian viruses and bacteriophages, Viruses, 2012, 4, 1034–1074.
M. Wainwright, Local treatment of viral disease using photodynamic therapy, Int. J. Antimicrob. Agents, 2003, 21, 510–520.
F. Pereira Gonzales and T. Maisch, Photodynamic inacti-vation for controlling Candida albicans infections, Fungal Biol., 2012, 116, 1–10.
P. Calzavara-Pinton, M. T. Rossi, R. Sala and M. Venturini, Photodynamic antifungal chemotherapy, Photochem. Photobiol., 2012, 88, 512–522.
M. P. Paz-Cristobal, D. Royo, A. Rezusta, E. Andres-Ciriano, M. C. Alejandre, J. F. Meis, M. J. Revillo, C. Aspiroz, S. Nonell and Y. Gilaberte, Photodynamic fun-gicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains, Mycoses, 2014, 57, 35–42.
Y. Arenas, S. Monro, G. Shi, A. Mandel, S. McFarland and L. Lilge, Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers, Photodiagn. Photodyn. Ther., 2013, 10, 615–625.
F. F. Sperandio, Y. Y. Huang and M. R. Hamblin, Antimicrobial photodynamic therapy to kill Gram-negative bacteria, Recent Pat. Antiinfect Drug Discov., 2013, 8, 108–120.
M. Magaraggia, F. Faccenda, A. Gandolfi and G. Jori, Treatment of microbiologically polluted aquaculture waters by a novel photochemical technique of potentially low environmental impact, J. Environ. Monit., 2006, 8, 923–931.
R. Bonnett, M. A. Krysteva, I. G. Lalov and S. V. Artarsky, Water disinfection using photosensitizers immobilized on chitosan, Water Res., 2006, 40, 1269–1275.
L. Brovko, Photodynamic treatment: a new efficient alternative for surface sanitation, Adv. Food Nutr. Res., 2010, 61, 119–147.
Acknowledgments
We would like to acknowledge Régis Vanderesse for his kind help in writing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larue, L., Ben Mihoub, A., Youssef, Z. et al. Using X-rays in photodynamic therapy: an overview. Photochem Photobiol Sci 17, 1612–1650 (2018). https://doi.org/10.1039/c8pp00112j
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c8pp00112j